Status:
RECRUITING
Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer.
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Conditions:
Ductal Breast Carcinoma in Situ
Invasive Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
An explanatory study comparing complementary treatment to breast conservative surgery with radiation therapy DCIS, T1-T2 N0 M0 (AJCC v8) 1 week schedule vs 3.1 weeks standard schedule, in order to det...
Detailed Description
PRIMARY OBJECTIVE: I. Compare the effectiveness of hypofractionated radiotherapy (1 week) with standard treatment (3.1 weeks) in the local control of breast cancer treated with conservative surgery. ...
Eligibility Criteria
Inclusion
- Patients diagnosed by histopathological report of ductal carcinoma in situ (DCIS) or invasive breast carcinoma.
- Treated with breast-conserving surgery and stage pT1-2 pN0 M0.
- Over 18 years.
- Patients who sign informed consent for research study.
Exclusion
- Positive nodes.
- Clinical or pathological stage T3-T4.
- History of previous irradiation.
- Postoperative positive margin.
Key Trial Info
Start Date :
April 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT05318274
Start Date
April 26 2021
End Date
June 30 2026
Last Update
November 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidad Medica de Alta Especialidad
Mérida, Yucatán, Mexico, 97150